Holen Sie sich die Stockscreener-App
21.64
0.05%
0.01
Handel nachbörslich:
21.65
0.010
+0.05%
Schlusskurs vom Vortag:
$21.63
Offen:
$21.66
24-Stunden-Volumen:
35.02M
Relative Volume:
14.65
Marktkapitalisierung:
$2.12B
Einnahmen:
$221.08M
Nettoeinkommen (Verlust:
$-2.92M
KGV:
-655.76
EPS:
-0.033
Netto-Cashflow:
$5.89M
1W Leistung:
+0.32%
1M Leistung:
+0.65%
6M Leistung:
+69.19%
1J Leistung:
+140.44%
1-Tages-Spanne:
$21.63
$21.76
1-Wochen-Bereich:
$21.57
$21.76
52-Wochen-Spanne:
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Firmenname
Avadel Pharmaceuticals Plc
Sektor
Telefon
636-449-1830
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Compare AVDL vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
21.64 | 2.12B | 221.08M | -2.92M | 5.89M | -0.033 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-09-03 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-07-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-06-12 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-03-05 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-05 | Bestätigt | Needham | Buy |
| 2024-03-05 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2022-11-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-28 | Fortgesetzt | Craig Hallum | Buy |
| 2022-05-26 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2020-07-31 | Eingeleitet | Oppenheimer | Outperform |
| 2020-07-21 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-03 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Eingeleitet | Stifel | Buy |
| 2020-02-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-30 | Eingeleitet | Craig Hallum | Buy |
| 2019-06-14 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
Alle ansehen
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
Form 8.3 -Avadel Pharmaceuticals plc - The Manila Times
Irish High Court sanctions Avadel Pharmaceuticals acquisition by Alkermes - TipRanks
Alkermes (ALKS) Set to Finalize Acquisition of Avadel Pharmaceuticals - GuruFocus
Avadel Pharmaceuticals plc Announces High Court Approval of Scheme of Arrangement for Acquisition by Alkermes plc - Quiver Quantitative
Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing - The Manila Times
Irish court clears Alkermes buyout; Avadel stock trading ends Feb. 11 - Stock Titan
Alkermes Increases Offer for Avadel Acquisition - MSN
Penserra Capital Management LLC Buys New Holdings in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Goldman Sachs (EPT)Form 38.5b- AVADEL PHARMACEUTICALS PLC - Research Tree
Market Review: Is Avadel Pharmaceuticals plc vulnerable to short sellersJuly 2025 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Sees Large Increase in Short Interest - MarketBeat
Macro Review: Will CMBT outperform tech stocksEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
Bank of America discloses 2.39% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Responsive Playbooks and the AVDL Inflection - Stock Traders Daily
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Is Avadel Pharmaceuticals plc on track to beat earningsEarnings Beat & Reliable Breakout Forecasts - Mfd.ru
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal - Investing.com Nigeria
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal By Investing.com - Investing.com India
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Swing Trade: Will ChargePoint Holdings Inc benefit from seasonalityJuly 2025 Action & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Pass Above 200 Day Moving AverageTime to Sell? - MarketBeat
Understanding the Setup: (AVDL) and Scalable Risk - Stock Traders Daily
Avadel Sets Court Date for Alkermes Acquisition Scheme - TipRanks
Avadel Pharmaceuticals Announces Court Hearing for Acquisition - TradingView — Track All Markets
Avadel (NASDAQ: AVDL) moves Alkermes acquisition forward with Irish court hearing date - Stock Titan
Avadel Pharmaceuticals appoints Susan Rodriguez as COO - MSN
State Street Increases Stake in Avadel Pharmaceuticals by 2.39% - intellectia.ai
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Avadel Pharmaceuticals (AVDL) Investor Outlook: Navigating a 54.90% Revenue Growth Amidst a Hold-Heavy Consensus - DirectorsTalk Interviews
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals - Investing.com
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals - Investing.com
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals - Investing.com India
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals - Investing.com India
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com India
Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.21%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):